Using gene therapy to protect and restore cartilage

Clinical Orthopaedics and Related Research

Volumn 379, Issue SUPPL., 2000, Pages

  Evans, C H ^a   Ghivizzani, S C ^a   Smith, P ^a   Shuler, F D ^a   Mi, Z ^a   Robbins, P D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROPROTECTIVE AGENT; CYTOKINE RECEPTOR; GENE PRODUCT; RECEPTOR BLOCKING AGENT; VIRUS VECTOR;

CARTILAGE CELL; CARTILAGE DEGENERATION; CELL PROTECTION; CHONDROGENESIS; CHONDROPATHY; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; GENE TRANSFER; MESENCHYME; PRIORITY JOURNAL; SYNOVIOCYTE; TISSUE REPAIR;

EID: 0033775224     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200010001-00027     Document Type: Conference Paper

References (43)

1. Adenovirus-vector mediated gene transduction to chondrocytes: In vitro evaluation of therapeutic efficiency of transforming growth factor-β1 and heat shock protein 70 gene transduction
2. Adenoviral-mediated transfer of active transforming growth factor-β1 in the murine knee joint induces fibrosis and osteophyte formation
3. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from osteogenesis imperfecta mouse (oim)
4. Gene transfer to synoviocytes: Prospects for gene treatment for arthritis
5. Transplantation of transduced chondrocytes protects cartilage from interleukin-1 induced extracellular matrix degradation
6. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo
7. Histological evaluation of the course of healing of canine articular cartilage defects treated with cultured autologous chondrocytes
8. Articular cartilage repair and transplantation
9. Mesenchymal stem cells and gene therapy
10. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate and collagen hydrolysate
11. Resurfacing of articular cartilage explants with genetically modified human chondrocytes in vitro
12. Gene therapy for rheumatic diseases
13. Lessons learned from gene transfer approaches
14. Possible orthopaedic applications of gene therapy
15. Genetically augmented tissue engineering of the musculoskeletal system
16. Potential treatment of osteoarthritis by gene therapy
17. Clinical trial to assess the safety, feasibility and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
18. In vivo transfer of interleukin-1 receptor antagonist gene in octeoarthritic rabbit knee joints: Prevention of osteoarthritic progression
19. Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis
20. Cartilage injury and repair
21. Transfer of LacZ marker gene to the meniscus
22. Gene therapy for meniscal injury: Enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGF-β1 gene
23. Adenovirus mediated gene delivery to the joints of guinea pigs
24. Orthopaedic applications of gene therapy: From concept to clinic
25. Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study
26. Efficient lipid-mediated gene transfer to articular chondrocytes
27. Restoration of the osteoarthritic joint
28. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells
29. Expression of human bone morphogenetic protein 7 in primary rabbit periosteal cells: Potential utility in gene therapy for osteochondral repair
30. Cartilage and bone regeneration using gene enhanced tissue engineering
31. Current concepts in the treatment of articular cartilage defects
32. Mesenchymal stem cells as vehicles for gene delivery: Transduction of eight species and biodistribution in a canine model
33. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective
34. Insulin-like growth factor-1 gene therapy in cartilage repair and degenerative joint diseases
35. Suppression of antigen-induced arthritis by gene therapy
36. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persists in bone and retains the ability to form cartilage and bone after extended passaging
37. In vivo suppression of early experimental osteoarthritis by IL-1Ra using gene therapy
38. The adeno-associated virus vector for orthopaedic gene therapy
39. Increased matrix synthesis following adenoviral transfer of a transforming growth factor-β1 gene into articular chondrocytes
40. Smith P, Shuler FD, Georgescu HI, et al: Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factors in the presence or absence of interleukin-1
41. Tomita T, Hashimoto H, Tomita N, et al: In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (sendai) virus and liposomes
42. Wakitani S, Goto T, Pineda SJ, et al: Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage
43. Yoo U, Mandell I, Angele P, et al: Chondroprogenitor cells and gene therapy. Clin Orthop 379S (Suppl)